ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

Prizes and Awards Acute Leukemias XIV Munich 2013

Leukemia Clinical Research Award 2013 of the DGHO:

Dr. med. Cyrus Khandanpour, University Hospital Essen, Germany

 

5 Best of Free Contributions:

Poster # 13: J. De Rijck, H. Méreau, K. Cermßaková, A. Kutz, S. Juge, J. de Meulemeester, R. Gijsbers, F. Christ, Z. Debyser, and J. Schwaller

IMPAIRING MLL-FUSION GENE MEDIATED TRANSFORMATION BY DISSECTING CRITICAL INTERACTIONS WITH THE LENS EPITHELIAL-DERIVED GROWTH FACTOR (LEDGF/P75)

Poster # 39:  F. Ravandi, M.L. Alattar, M. Levis, St. Faderl, J. Burger, M. Grunwald, J. Cortes, H. Kantarjian

PHASE II STUDY OF SORAFENIB AND 5-AZACYTIDINE (AZA) IN PATIENTS WITH RELAPSED, REFRACTORY OR UNTREATED AML AND FLT3-ITD MUTATION

Poster # 37: D. Thomas, J. Powell, F. Vergez, E.F. Barry, J.E. Sarry, N. Truong, S. Manenti, C. Récher, A.H. Wei, and M.A. Guthridge

THERAPEUTIC TARGETING OF P13K AND CDK9 IN AML

Poster # 54: Ch. Gawad, M. Borowitz, G. Dahl, M. Devidas, M. Faham, M. Moorhead, B. Wood, J. Zhen, M. Loh, and N. Lacayo

COMPARISON OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURING MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIAS: A CHILDREN'S ONCOLOGY GROUP COHORT

Poster # 56: M.N. Hasan, M. Queudeville, S.M. Eckhoff, L. Trentin, K.M. Debatin, and L.H. Meyer

PRECLINICAL EVALUATION OF A NOVEL TREATMENT STRATEGY FOR HIGH RISK ALL

 

Poster Awards:

Poster # 18: G. Göhring, S. Feuerstein, W. Hofmann, A. Ganser, Hans Kreipe, and B. Schlegelberger

MYELODYSPLASTIC SYNDROME WITH DEL(5Q): ROUTES OF CLONAL EVOLUTION INTO AML WITH COMPLEX KARYOTYPES

Poster # 43: C. Wang, S. Vosberg, S. Krebs, B. Ksienzy, S. Opatz, M. Hubmann, E. Zellmeier, S. Schneider, A. Graf, H. Blum, K. Spiekermann, S.K. Bohlander, and P.A. Greif

MINIMAL RESIDUAL DISEAASE (MRD) DIAGNOSTICS IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS USING HIGH-THROUGHPUT NPM1 AMPLICON SEQUENCING